Aptorum Group shares rise 11.72% intraday after merging with DiamiR Biosciences and adding Dr. Laura A. Philips to board.

Aptorum Group surged 11.72% intraday following news of its merger with DiamiR Biosciences Corp. and the appointment of Dr. Laura A. Philips to its board. The merger and strategic leadership addition are seen as positive developments, potentially signaling enhanced operational focus or growth opportunities for the nano-cap biotech firm. While the news headline initially referenced a stock decline, the core event—executing the merger and strengthening board expertise—aligns with the upward price movement, suggesting market optimism over the company’s post-merger direction.